Medicare Enrolled
Dr. Gordon Handelsman, M.D
Family Medicine · Munhall, PA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Handelsman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Handelsman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Handelsman
Dr. Gordon Handelsman is a family medicine specialist in Munhall, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Handelsman performed 1,186 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Handelsman received a total of $15,139 from 47 pharmaceutical and/or device companies across 974 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Handelsman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 21% volume in PA
$15,139 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,186
Medicare services
Top 21% in PA for family medicine
Not available
Unique patients (not deduplicated)
$68
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
396 | $87 | $300 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
128 | $75 | $135 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
119 | $10 | $38 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
118 | $126 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
86 | $14 | $75 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
83 | $10 | $24 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
75 | $61 | $225 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
36 | $29 | $55 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
33 | $72 | $95 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
33 | $127 | $400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
29 | $60 | $250 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
20 | $2 | $12 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
18 | $129 | $451 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
12 | $215 | $505 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,139
Total received (2018-2024)
Avg $2,163/year across 7 years
Top 3% in PA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
47
Companies
974
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,879
2023
$2,472
2022
$2,264
2021
$2,517
2020
$1,514
2019
$1,833
2018
$1,659
Payments by company (2024)
GlaxoSmithKline, LLC.
$596
AstraZeneca Pharmaceuticals LP
$532
ABBVIE INC.
$322
Novo Nordisk Inc
$289
Lilly USA, LLC
$211
Janssen Pharmaceuticals, Inc
$136
Boehringer Ingelheim Pharmaceuticals, Inc.
$129
Exact Sciences Corporation
$128
Amgen Inc.
$105
Phathom Pharmaceuticals, Inc.
$98
Esperion Therapeutics, Inc.
$96
Merck Sharp & Dohme LLC
$69
Novartis Pharmaceuticals Corporation
$53
PFIZER INC.
$33
Abbott Laboratories
$30
SHIELD THERAPEUTICS INC
$21
Antares Pharma, Inc.
$17
Azurity Pharmaceuticals, Inc.
$13
Top 3 companies account for 50.4% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$2,921
Novo Nordisk Inc
$2,400
AstraZeneca Pharmaceuticals LP
$1,190
Janssen Pharmaceuticals, Inc
$1,127
Lilly USA, LLC
$836
ABBVIE INC.
$772
Novartis Pharmaceuticals Corporation
$710
E.R. Squibb & Sons, L.L.C.
$685
PFIZER INC.
$641
Boehringer Ingelheim Pharmaceuticals, Inc.
$623
Merck Sharp & Dohme LLC
$433
Amarin Pharma Inc.
$364
Merck Sharp & Dohme Corporation
$257
Abbott Laboratories
$254
Amgen Inc.
$220
SANOFI-AVENTIS U.S. LLC
$190
Exact Sciences Corporation
$153
Bayer HealthCare Pharmaceuticals Inc.
$153
MannKind Corporation
$152
Astellas Pharma US Inc
$149
Phathom Pharmaceuticals, Inc.
$98
Esperion Therapeutics, Inc.
$96
Kowa Pharmaceuticals America, Inc.
$82
Collegium Pharmaceutical, Inc.
$82
Biohaven Pharmaceutical Holding Company Ltd.
$49
Allergan, Inc.
$40
Teva Pharmaceuticals USA, Inc.
$39
AbbVie Inc.
$36
Philips Electronics North America Corporation
$34
UCB, Inc.
$32
Hikma Pharmaceuticals USA
$30
Gilead Sciences, Inc.
$25
Seqirus USA Inc
$24
Amneal Pharmaceuticals LLC
$21
SHIELD THERAPEUTICS INC
$21
Scilex Pharmaceuticals Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
Dexcom, Inc.
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$19
Antares Pharma, Inc.
$17
Almatica Pharma LLC
$17
Biogen, Inc.
$17
Avanir Pharmaceuticals, Inc.
$16
Purdue Pharma L.P.
$15
SANOFI PASTEUR INC.
$15
Azurity Pharmaceuticals, Inc.
$13
DEXCOM, INC.
$11
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ACCRUFER · ADVAIR · AFREZZA · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Aimovig · AirDuo Digihaler · BASAGLAR · BELSOMRA · BEVESPI AEROSPHERE · BEXSERO · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · BRILINTA · Briviact · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · EDARBI · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · FARXIGA · FLUZONE HIGH-DOSE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · Fluad · FreeStyle Libre 2 · GARDASIL · GARDASIL 9 · GRALISE · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LYRICA · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · NEXLETOL · NUEDEXTA · NURTEC ODT · Neupro · Otezla · Ozempic · PAXLOVID · PREVNAR 20 · PROCLAIM · Proclaim IPG · QULIPTA · RYBELSUS · Rybelsus · SOLIQUA 100/33 · SPINRAZA · SPRAVATO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYMPROIC · TOUJEO · TOVIAZ · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · UNITHROID · VAQTA · VERQUVO · VOQUEZNA · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · XTAMPZA · XYOSTED · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
904
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
MAGEE WOMENS HOSPITAL OF UPMC HEALTH SYSTEM
4.0 mi
4.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Handelsman is a clinical cardiology specialist, with above-average Medicare volume (top 21% in PA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Handelsman experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Handelsman performed 396 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Handelsman receive payments from pharmaceutical companies?
Yes. Dr. Handelsman received a total of $15,139 from 47 companies across 974 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Handelsman's costs compare to other family medicine physicians in Munhall?
Dr. Handelsman's average Medicare payment per service is $68. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Handelsman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Munhall
Browse family medicine physicians in Munhall ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in PA
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in PA
Which PA family medicine physicians receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology